Nucleate's Activator forms pioneering biotech companies without taking equity. Timeline and FAQ.
Deadline for US chapters is October 21st. Deadline for international chapters will vary. Please contact your local chapter to verify.
REQUIREMENTS
01
Approval from PI
02
Well defined technology / product backed by preliminary scientific research (Therapeutic modalities - Platform technologies - Diagnostics - Medical Devices)
03
Existing IP to protect the technology, or clear path to file IP within the next year
04
Clear potential to apply the technology
05
Team intending and willing to 'spin-out' in the near future
This site uses cookies to ensure that you get the best experience possible. Learn more